|
Alembic Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
13081.28 Cr.
|
P/BV
|
2.40
|
Book Value (Rs.)
|
277.42
|
|
52 Week High/Low (Rs.)
|
1108/652
|
FV/ML
|
2/1
|
P/E(X)
|
22.42
|
|
Bookclosure
|
29/07/2025
|
EPS (Rs.)
|
29.68
|
Div Yield (%)
|
1.65
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 29.68 | 31.33 | 17.40 | 26.50 | 60.81 |
| Diluted EPS (Rs.) | 29.68 | 31.33 | 17.40 | 26.50 | 60.81 |
| Cash EPS (Rs.) | 43.74 | 45.25 | 32.99 | 40.83 | 66.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 264.10 | 245.14 | 222.36 | 266.47 | 257.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 264.10 | 245.14 | 222.36 | 266.47 | 257.80 |
| Revenue From Operations / Share (Rs.) | 339.46 | 316.90 | 287.59 | 269.95 | 274.39 |
| PBDIT / Share (Rs.) | 53.46 | 48.93 | 36.18 | 47.04 | 79.75 |
| PBIT / Share (Rs.) | 39.29 | 35.05 | 22.17 | 32.45 | 70.42 |
| PBT / Share (Rs.) | 35.94 | 32.20 | 19.61 | 31.55 | 69.60 |
| Net Profit / Share (Rs.) | 29.57 | 31.38 | 18.97 | 26.23 | 56.72 |
| NP After MI And SOA / Share (Rs.) | 29.68 | 31.33 | 17.40 | 26.50 | 59.94 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 15.74 | 15.43 | 12.58 | 17.42 | 29.06 |
| PBIT Margin (%) | 11.57 | 11.06 | 7.70 | 12.02 | 25.66 |
| PBT Margin (%) | 10.58 | 10.15 | 6.82 | 11.68 | 25.36 |
| Net Profit Margin (%) | 8.71 | 9.90 | 6.59 | 9.71 | 20.67 |
| NP After MI And SOA Margin (%) | 8.74 | 9.88 | 6.05 | 9.81 | 21.84 |
| Return on Networth / Equity (%) | 11.23 | 12.78 | 7.82 | 9.94 | 22.97 |
| Return on Capital Employeed (%) | 14.40 | 13.80 | 9.58 | 11.79 | 25.49 |
| Return On Assets (%) | 7.50 | 9.55 | 5.53 | 7.31 | 17.56 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Total Debt / Equity (X) | 0.23 | 0.08 | 0.14 | 0.12 | 0.03 |
| Asset Turnover Ratio (%) | 0.93 | 0.98 | 0.77 | 0.73 | 0.79 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.69 | 2.12 | 1.78 | 1.67 | 2.01 |
| Quick Ratio (X) | 0.74 | 0.98 | 0.87 | 0.72 | 0.85 |
| Inventory Turnover Ratio (X) | 3.39 | 0.89 | 0.86 | 0.78 | 0.93 |
| Dividend Payout Ratio (NP) (%) | 37.06 | 25.53 | 57.47 | 52.82 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 25.08 | 17.69 | 31.83 | 34.06 | 0.00 |
| Earning Retention Ratio (%) | 62.94 | 74.47 | 42.53 | 47.18 | 0.00 |
| Cash Earning Retention Ratio (%) | 74.92 | 82.31 | 68.17 | 65.94 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 13.34 | 17.11 | 14.17 | 52.15 | 97.85 |
| Interest Coverage Ratio (Post Tax) (%) | 8.21 | 11.98 | 8.43 | 30.08 | 70.59 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 19368.46 | 19611.97 | 10301.50 | 15131.79 | 19003.45 |
| EV / Net Operating Revenue (X) | 2.90 | 3.15 | 1.82 | 2.85 | 3.52 |
| EV / EBITDA (X) | 18.43 | 20.39 | 14.49 | 16.37 | 12.12 |
| MarketCap / Net Operating Revenue (X) | 2.74 | 3.10 | 1.72 | 2.75 | 3.52 |
| Retention Ratios (%) | 62.93 | 74.46 | 42.52 | 47.17 | 0.00 |
| Price / BV (X) | 3.52 | 4.01 | 2.23 | 2.78 | 3.70 |
| Price / Net Operating Revenue (X) | 2.74 | 3.10 | 1.72 | 2.75 | 3.52 |
| EarningsYield | 0.03 | 0.03 | 0.03 | 0.03 | 0.06 |
